𧬠ICD-10 CM E11.3212 β Type 2 Diabetes Mellitus With Mild Nonproliferative Diabetic Retinopathy With Macular Edema, Left Eye
Billable Code Confirmed
ICD-10-CM E11.3212 is a valid, billable 7-character ICD-10-CM code for FY2026. The 7th character (β2β) defines the strict laterality for the left eye. No additional characters are required.
Non-Billable Parent Codes β Never Submit These
- β
E11β 3-character header β Lacks complication specificity.- β
E11.3β 4-character header β Lacks specific ophthalmic complication.- β
E11.32β 5-character header β Lacks macular edema and laterality specificity.- β
E11.321β 6-character header β Lacks laterality (right/left/bilateral) specificity.Always submit E11.3212 (all 7 characters) when mild NPDR with macular edema in the left eye is documented.
Clinical Context: The Presence of Macular Edema
ICD-10-CM E11.3212 captures the critical distinction of macular edema alongside the mild retinopathy. Macular edema (fluid leaking into the macula) is the leading cause of vision loss in diabetics and drastically changes the clinical management plan (e.g., initiating anti-VEGF injections rather than just observation), making its accurate capture essential for both medical necessity and severity of illness.
Code Classification
ICD-10-CM Diagnosis Code β wRVU, assistant payable, and global period fields are not applicable to diagnosis codes. See the Commonly Associated CPT Codes and ICD-10-PCS Crosswalk sections below for procedural billing pairings.
π Code Description
ICD-10-CM E11.3212 classifies Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye. This code indicates that a patient with Type 2 diabetes has developed early-stage retinal microvascular damage (mild NPDR) in their left eye, accompanied by the swelling of the macula due to fluid leakage from these compromised vessels.
Pathophysiologically, chronic hyperglycemia damages the pericytes of the retinal capillaries, leading to microaneurysmsβthe hallmark of mild nonproliferative diabetic retinopathy. When these abnormal microaneurysms or weakened capillaries leak fluid and lipids into the central retina (macula), it creates diabetic macular edema (DME), threatening central visual acuity.
π³ Code Tree / Hierarchy
E11 Type 2 diabetes mellitus β Non-billable
β
βββ E11.2 Type 2 diabetes mellitus with kidney complications β Non-billable
βββ E11.3 Type 2 diabetes mellitus with ophthalmic complications β Non-billable
β β
β βββ E11.31 Type 2 diabetes mellitus with unspecified diabetic retinopathy β Non-billable
β βββ E11.32 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy β Non-billable
β β β
β β βββ E11.321 Type 2 diabetes with mild NPDR with macular edema β Non-billable
β β β β
β β β βββ E11.3211 Type 2 diabetes with mild NPDR with macular edema, right eye β
Billable
β β β βββ E11.3212 Type 2 diabetes with mild NPDR with macular edema, left eye β THIS CODE β
Billable
β β β
β β βββ E11.329 Type 2 diabetes with mild NPDR without macular edema β Non-billable
β β
β βββ E11.33 Type 2 diabetes with moderate nonproliferative diabetic retinopathy β Non-billable
β
βββ E11.4 Type 2 diabetes mellitus with neurological complications β Non-billable
Coding for Laterality and Edema
Selecting the 6th character β1β confirms the presence of macular edema, and the 7th character β2β dictates the left eye. If the right eye has moderate NPDR and the left eye has mild NPDR with edema, you must code both specific conditions separately (e.g.,
[[E11.3391]]and[[E11.3212]]).
β Includes
The following clinical terms and scenarios map to E11.3212 when documented for the left eye:
- Mild background diabetic retinopathy with clinically significant macular edema (CSME)
- Type 2 diabetic maculopathy secondary to mild NPDR
- Early nonproliferative diabetic retinopathy with central retinal swelling
β Excludes
Excludes 1 β Cannot Be Coded Simultaneously with E11.3212
| Code | Description | Note |
|---|---|---|
| E10.3212 | Type 1 diabetes mellitus with mild NPDR with macular edema, left eye | Mutually exclusive. A patient is classified as having Type 1 OR Type 2 diabetes, not both. |
| E08.3212 | Diabetes mellitus due to underlying condition with mild NPDR with macular edema, left eye | Mutually exclusive. Code E08 is for diabetes caused by another condition (e.g., cystic fibrosis, pancreatectomy). |
Excludes 1 Violation Risk
A common error is defaulting to an
E11.-code for a patient with Type 1 diabetes simply because they are on insulin. Always verify the type of diabetes in the medical record. If the patient has Type 1 diabetes, you must use theE10.-category.
Excludes 2 β May Be Coded in Addition if Separately Present
| Code | Description | Note |
|---|---|---|
| H28 | Cataract in diseases classified elsewhere | Code first the underlying diabetes ([[E11.3212]]), then [[H28]] if a diabetic cataract is also present in the eye. |
| Z79.4 | Long term (current) use of insulin | Should be coded additionally if the Type 2 diabetic patient requires long-term insulin therapy for control. |
π Clinical Overview
Retinopathy Stage Distinction
Accurate stage assignment by the provider directly impacts the ICD-10-CM category selected.
| Feature | E11.3212 β Mild NPDR | E11.3312 β Moderate NPDR | E11.3412 β Severe NPDR |
|---|---|---|---|
| Vascular Findings | Microaneurysms only. | Microaneurysms, dot/blot hemorrhages, hard exudates. | Extensive hemorrhages, venous beading, IRMA (Intraretinal microvascular abnormalities). |
| Macular Edema | Present (in this specific code). | Present (if 6th character is 1). | Present (if 6th character is 1). |
| Risk of Vision Loss | Moderate (driven primarily by the edema, not the vascular proliferation). | High. | Very High (imminent risk of proliferative disease). |
Documentation Tip β "Background Retinopathy"
Providers often use the legacy term βbackground diabetic retinopathyβ (BDR). For coding purposes, BDR translates to βnonproliferative diabetic retinopathyβ (NPDR). If the provider documents BDR but doesnβt specify mild, moderate, or severe, the coder may have to default to an unspecified code. Query the provider for the exact severity to support code
[[E11.3212]].
Manifestations & Symptom Burden
Common clinical indications documented alongside this diagnosis:
- Central visual blurring or distortion: Secondary to fluid accumulation in the fovea.
- Microaneurysms: Visible on fundus examination.
- Increased retinal thickness: Documented via Optical Coherence Tomography (OCT).
Coding Manifestations
π° HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (2024-2025 Implementation) |
| HCC Assignment | β Mapped β HCC 37 |
| HCC Category | HCC 37 β Diabetes with Chronic Complications |
| RAF Coefficient | ~0.166 (varies by demographic/status and interaction factors) |
E11.3212 maps directly to an HCC and contributes to the RAF score.
Capture Annually
Chronic conditions like diabetic retinopathy must be evaluated, documented (M. E. A. T Criteria criteria: Monitor, Evaluate, Assess, Treat), and coded at least once every calendar year to accurately forecast the patientβs resource utilization and fund their Medicare Advantage risk pool. Failure to code this annually will drop the patientβs RAF score.
π₯ DRG Assignment
MDC 10 β Endocrine, Nutritional and Metabolic Diseases and Disorders
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 637 | Diabetes with MCC | ~1.65 - 1.85 |
| DRG 638 | Diabetes with CC | ~0.95 - 1.15 |
| DRG 639 | Diabetes without CC/MCC | ~0.65 - 0.75 |
Approximate. Verify against IPPS FY2026 Final Rule tables.
Sequencing and Complications
If a patient is admitted for uncontrolled diabetes or a diabetic crisis, the E11.- codes sequence first.
[[E11.3212]]is typically sequenced as a secondary diagnosis when admitted for unrelated issues (e.g., pneumonia or orthopedic surgery) and functions as a Complication or Comorbidity (CC) under the MS-DRG logic, acknowledging the higher nursing care and monitoring required for advanced diabetics.
π Related ICD-10-CM Codes
Laterality and Edema Variants
| Code | Description |
|---|---|
| E11.3211 | Type 2 diabetes with mild NPDR with macular edema, right eye |
| E11.3212 | Type 2 diabetes with mild NPDR with macular edema, left eye β This Code |
| E11.3213 | Type 2 diabetes with mild NPDR with macular edema, bilateral |
| E11.3292 | Type 2 diabetes with mild NPDR without macular edema, left eye |
Disease Progression Variants
| Code | Description |
|---|---|
| E11.3312 | Type 2 diabetes with moderate NPDR with macular edema, left eye |
| E11.3412 | Type 2 diabetes with severe NPDR with macular edema, left eye |
| E11.3512 | Type 2 diabetes with proliferative diabetic retinopathy with macular edema, left eye |
π οΈ Commonly Associated CPT Codes (Outpatient / Profee Setting)
Outpatient and Profee Setting Context
This diagnosis is predominantly managed in the outpatient ophthalmology or retina specialist setting. Diagnostic imaging and therapeutic injections are highly typical.
| CPT Code | Description | Profee Coding Notes (Modifier 26) |
|---|---|---|
| 92134 | Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina | Requires medical necessity; [[E11.3212]] strongly supports this. Billed globally or with -26/-TC depending on equipment ownership. |
| 92250 | Fundus photography with interpretation and report | Used to document the baseline microaneurysms. NCCI edits often bundle this with OCT (92134); check payer rules before billing both on the same day. |
| 67028 | Intravitreal injection of a pharmacologic agent (separate procedure) | The surgical procedure for injecting anti-VEGF medication to treat the macular edema. Append modifier -LT to match the left eye diagnosis. |
| J2778 | Injection, ranibizumab, 0.1 mg | HCPCS code for the drug (Lucentis) injected during 67028. |
NCCI Bundling Considerations
- CPT 92134 (OCT Retina) billed on the same day as CPT 92250 (Fundus Photography) is often bundled by Medicare. A modifier (like -59) is only appropriate if the diagnostic studies are performed for distinctly different, medically necessary reasons that are clearly documented.
π Coding Scenarios and Examples
Scenario 1 β Outpatient Retina Clinic: Intravitreal Injection
Clinical Vignette: A 65-year-old female with a 15-year history of Type 2 diabetes presents for scheduled management of her left eye vision blurring. Previous OCT showed increased foveal thickness, and fundus exam noted scattered microaneurysms without hemorrhages. Today, her blood sugars are stable. We proceeded with a left eye intravitreal injection of aflibercept to treat the central macular swelling.
CPT / HCPCS (Profee):
- 67028-LT β Intravitreal injection of a pharmacologic agent, left eye
- J0178 β Injection, aflibercept, 1 mg (units billed according to dose)
ICD-10-CM:
- E11.3212 β Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye (Supports the medical necessity for the anti-VEGF injection)
Scenario 2 β Inpatient: Admitted for Glycemic Control
Clinical Vignette: A 70-year-old male with Type 2 diabetes is admitted for hyperosmolar hyperglycemic state (HHS). His blood sugars are in the 600s. During the admission history, he notes he is actively receiving treatment from his ophthalmologist for mild diabetic retinopathy and swelling in his left retina. Endocrine is consulted to establish an insulin pump regimen.
Principal Diagnosis:
- E11.00 β Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
Secondary Diagnoses:
- E11.3212 β Type 2 diabetes with mild NPDR with macular edema, left eye (Functions as a CC)
- Z79.4 β Long term (current) use of insulin
MS-DRG Assignment: Groups to DRG 638 (Diabetes with CC) due to the presence of the diabetic complication codes.
Scenario 3 β CDI Query: Vague Eye Exam Documentation
Clinical Vignette: An internistβs progress note reads: βPatient is a Type 2 diabetic. Eye specialist notes from last week show they have diabetic background retinopathy and some fluid in the macula of the left eye. Blood sugar well controlled on metformin.β
Action / Outcome: βBackground retinopathyβ is an older term that translates to nonproliferative retinopathy, but it lacks the severity level (mild, moderate, severe) required for ICD-10-CM specificity.
Query Response: Provider updates documentation to confirm: βThe patient has mild nonproliferative diabetic retinopathy with macular edema in the left eye based on the ophthalmology consult.β
Corrected ICD-10-CM Coding:
- E11.3212 β Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye
- Z79.84 β Long term (current) use of oral hypoglycemic drugs
β οΈ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| β | Defaulting to Unspecified Eye. Coding E11.3219 (unspecified eye) frequently leads to claim denials, especially for unilateral procedures like intravitreal injections (CPT 67028-LT). Laterality must match. |
| β | Missing the Edema Designation. Selecting a code ending in β9β (e.g., E11.3292 - without macular edema) when anti-VEGF injections are billed will result in medical necessity denials, as the edema is the specific indication for the drug. |
| β | Code to the Highest Specificity Documented. If a patient has mild NPDR in the left eye and severe NPDR in the right eye, you must report two distinct diagnosis codes. Do not default to a bilateral code if the severity is asymmetrical. |
| β | Link to Drug Use. Always capture secondary codes for long-term insulin (Z79.4) or oral hypoglycemics (Z79.84) as these provide a complete clinical picture of the patientβs diabetes management. |
π Sources
CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026. Section I.C.4.a (Diabetes mellitus).American Academy of Ophthalmology (AAO). Diabetic Retinopathy Preferred Practice Pattern.
AMA. CPT Professional Edition 2026. Surgery / Eye and Ocular Adnexa.
CMS. 2025-2026 Medicare Advantage Risk Adjustment β CMS-HCC Model v28 ICD-10-CM Mappings.
CMS. IPPS Final Rule FY2026 β MS-DRG Definitions Manual v43. MDC 10 logic tables.
Crystal's Coder Hub